drugset / Trial / NCT06450392

The Effect of Local and Systemic Tranexamic Acid on Edema and Ecchymosis in Orbital Surgery

NCT06450392 ↗

Phase 4 Recruiting 150 enrolled Montefiore Medical Center
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Tranexamic acid (TXA) is a synthetic reversible competitive inhibitor to plasminogen lysine receptor, which prevents plasmin formation and stabilizes the fibrin matrix, thus reducing bleeding. While recent studies have demonstrated the antifibrinolytic benefits of TXA in obstetric and gynecologic conditions, traumatic hemorrhage, cardiac surgery, total knee arthroplasty, and more, there is a paucity of clinical data on TXA use in plastic surgery. The aim of this study is to evaluate the effect of local and systemic TXA on postoperative periocular ecchymosis/edema in orbital surgery.

Timeline

Start
2024-10-07
Primary completion
2027-01
Completion
2027-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 100 mg/ml Subcutaneous
Subject Tranexamic Acid Small molecule 1 g Subcutaneous